MEDIC — Medicon Hellas SA Share Price
Last trade - 00:00- €13.26m
- €16.24m
- €17.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.63 | ||
| Price to Tang. Book | 0.63 | ||
| Price to Free Cashflow | 3.5 | ||
| Price to Sales | 0.71 | ||
| EV to EBITDA | 3.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.13% | ||
| Return on Equity | 12.29% | ||
| Operating Margin | 16.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 21.51 | 20.77 | 18.12 | 18.12 | 17.95 | n/a | n/a | 3.3% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +295.19 | -15.32 | -53.03 | +11.28 | +27.42 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MEDICON HELLAS S.A. is a Greece-based company operating as a developer, manufacturer and distributor of in vitro diagnostic (IVD) products and healthcare solutions. The Company produces clinical chemistry, immunochemistry and hematology reagents, calibration and quality control materials, and supplies laboratory analytical systems and related equipment to hospitals, diagnostic laboratories and healthcare providers. It also imports and distributes diagnostic instruments from international manufacturers, develops laboratory and medical software applications, and provides diagnostic services through its laboratory network. In addition, the Company is active in the production of cosmetics and personal care products. MEDICON HELLAS serves customers in Greece and international markets through its manufacturing, research and distribution activities in the healthcare and diagnostics sector.
Directors
- Maria Dimotsantou CHM
- Spyridon Dimotsantos CEO (67)
- Evangelos Mpaltzoglou DCE (60)
- Georgios Kyridis CFO
- Vasileios Tsaousis VRD
- Dimitrios Martinos DSL
- Ioannis Prasinos DSL (59)
- Konstantinos Tsolakoglou DSL
- Andreas Stampoulis DIR
- Konstantinos Lalioutis OTH
- Chrysanthos Mitropoulos OTH (59)
- Georgios Psichas OTH
- Vaia Tzortsou OTH
- Georgios Dimotsantos DRC (25)
- Sotiria Mitropoulou DRC (35)
- Georgios-Konstantinos Mpaltzoglou DRC (28)
- Dimitrios Kapetanakis NID (32)
- Theodora Mitsiou NID (34)
- Dimitrios Stampoulis NID (67)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- January 14th, 1988
- Public Since
- July 11th, 2001
- No. of Employees
- 152
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Athens Exchange
- Shares in Issue
- 4,419,616
- Address
- Melitona 5-7, Gerakas, PALLINI, 153 44
- Web
- https://www.mediconsa.com
- Phone
- +30 2106606000
- Contact
- Andreas Stampoulis
- Auditors
- JPA
Latest News for MEDIC
Upcoming Events for MEDIC
FAQ
As of Today at 03:02 UTC, shares in Medicon Hellas SA are trading at €3.00. This share price information is delayed by 15 minutes.
Shares in Medicon Hellas SA last closed at €3.00 and the price had moved by +19.52% over the past 365 days. In terms of relative price strength the Medicon Hellas SA share price has outperformed the FTSE Global All Cap Index by +5.44% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Medicon Hellas SA dividend yield is 5% based on the trailing twelve month period.
Last year, Medicon Hellas SA paid a total dividend of €0.15, and it currently has a trailing dividend yield of 5%. We do not have any data on when Medicon Hellas SA is to next pay dividends.
We do not have data on when Medicon Hellas SA is to next pay dividends. The historic dividend yield on Medicon Hellas SA shares is currently 5%.
To buy shares in Medicon Hellas SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €3.00, shares in Medicon Hellas SA had a market capitalisation of €13.26m.
Here are the trading details for Medicon Hellas SA:
- Country of listing: Greece
- Exchange: ATH
- Ticker Symbol: MEDIC
Based on an overall assessment of its quality, value and momentum Medicon Hellas SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medicon Hellas SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +16.35%.
As of the last closing price of €3.00, shares in Medicon Hellas SA were trading +11.19% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medicon Hellas SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €3.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medicon Hellas SA's management team is headed by:
- Maria Dimotsantou - CHM
- Spyridon Dimotsantos - CEO
- Evangelos Mpaltzoglou - DCE
- Georgios Kyridis - CFO
- Vasileios Tsaousis - VRD
- Dimitrios Martinos - DSL
- Ioannis Prasinos - DSL
- Konstantinos Tsolakoglou - DSL
- Andreas Stampoulis - DIR
- Konstantinos Lalioutis - OTH
- Chrysanthos Mitropoulos - OTH
- Georgios Psichas - OTH
- Vaia Tzortsou - OTH
- Georgios Dimotsantos - DRC
- Sotiria Mitropoulou - DRC
- Georgios-Konstantinos Mpaltzoglou - DRC
- Dimitrios Kapetanakis - NID
- Theodora Mitsiou - NID
- Dimitrios Stampoulis - NID